MAP3K1
Top View
- PI3K/Akt/Mtor Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer David C
- Analysis of Map3k-Dependent Molecular Mechanisms Regulating Signaling
- Kinome Expression Profiling to Target New Therapeutic Avenues in Multiple Myeloma
- Rho Protein Gtpases and Their Interactions with Nfκb: Crossroads of Inflammation and Matrix Biology
- Supporting Information
- The Role of Receptor Tyrosine Kinase Axl in Pancreatic Ductal Adenocarcinoma and Its Regulation by Hematopoietic Progenitor Kinase 1
- Kinases That Are Currently Stored in the Phospho.ELM Database
- <I>MAP2K1</I> Mutation in a Patient with Langerhans Cell Histiocytosis
- Inhibition of Haspin Kinase Promotes Cell-Intrinsic and Extrinsic Antitumor Activity Johannes C
- Low Expression of Citron Kinase Is Associated with Poor Patient Outcomes in Hepatocellular Carcinoma
- Snapshot: Breast Cancer Kornelia Polyak and Otto Metzger Filho Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02215 USA
- Prevalence and Risk of Breast and Lung Cancer
- Supporting Information for “A High-Throughput Targeted Proteomic Approach for Comprehensive
- The One-Hundred Subclass-Defining Genes
- Inhibition of the JNK/MAPK Signaling Pathway by Myogenesis-Associated
- BF0055-MAP2K7 Ab
- Prevalence of Germline Mutations in Cancer Susceptibility Genes In
- MAP3K1 and MAP2K4 Mutations Are Associated with Sensitivity to MEK Inhibitors in Multiple Cancer Models